PADERI, AGNESE
 Distribuzione geografica
Continente #
NA - Nord America 348
EU - Europa 307
AS - Asia 73
AF - Africa 2
Totale 730
Nazione #
US - Stati Uniti d'America 345
RU - Federazione Russa 122
PL - Polonia 54
IT - Italia 52
IE - Irlanda 36
SG - Singapore 25
HK - Hong Kong 18
SE - Svezia 18
CN - Cina 14
JO - Giordania 12
CH - Svizzera 6
AT - Austria 5
GB - Regno Unito 5
BE - Belgio 2
CA - Canada 2
CI - Costa d'Avorio 2
DE - Germania 2
IN - India 2
LT - Lituania 2
VN - Vietnam 2
DK - Danimarca 1
FI - Finlandia 1
MX - Messico 1
NL - Olanda 1
Totale 730
Città #
Santa Clara 154
Warsaw 52
Dublin 36
Chandler 24
Fairfield 23
Singapore 23
Ashburn 17
Hong Kong 12
Woodbridge 10
Altamura 9
Seattle 9
Florence 8
Lawrence 8
Moscow 8
Bern 6
Houston 5
Vienna 5
Beijing 4
Boston 4
Princeton 4
Rome 4
Wilmington 4
Boardman 3
San Diego 3
San Marzano sul Sarno 3
Shanghai 3
Abidjan 2
Anguillara Sabazia 2
Bremen 2
Brussels 2
Buffalo 2
Cambridge 2
Dong Ket 2
London 2
Lucera 2
Milan 2
New York 2
Pune 2
Toronto 2
Ancona 1
Andover 1
Bagno A Ripoli 1
Falls Church 1
Helsinki 1
Hounslow 1
Jinan 1
Kent 1
Los Angeles 1
Marcallo con Casone 1
Norwalk 1
Phoenix 1
Redmond 1
Seregno 1
Trumbull 1
Vejle 1
Verona 1
Yubileyny 1
Totale 485
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 200
Update of NGS analysis of Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 126
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 102
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 93
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients 75
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 72
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 62
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 12
Totale 742
Categoria #
all - tutte 2.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 0 6 6 6 6 5 6 4
2020/202155 3 9 0 6 3 3 6 4 6 6 0 9
2021/202228 0 2 1 0 0 5 2 2 0 5 3 8
2022/2023149 6 27 3 11 7 26 16 14 21 3 7 8
2023/202488 1 5 7 7 12 16 3 17 4 5 7 4
2024/2025344 17 41 28 72 123 63 0 0 0 0 0 0
Totale 742